A detailed history of Black Rock Inc. transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Black Rock Inc. holds 131,726 shares of BHC stock, worth $1.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
131,726
Previous 218,000 39.58%
Holding current value
$1.2 Million
Previous $2.31 Million 60.29%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$6.1 - $10.41 $526,271 - $898,112
-86,274 Reduced 39.58%
131,726 $918,000
Q1 2024

May 10, 2024

BUY
$7.77 - $10.61 $35,081 - $47,904
4,515 Added 2.11%
218,000 $2.31 Million
Q4 2023

Feb 13, 2024

SELL
$6.53 - $8.23 $145,285 - $183,109
-22,249 Reduced 9.44%
213,485 $1.71 Million
Q3 2023

Nov 13, 2023

SELL
$7.69 - $9.71 $103,745 - $130,997
-13,491 Reduced 5.41%
235,734 $1.94 Million
Q2 2023

Aug 11, 2023

SELL
$5.72 - $8.8 $614,539 - $945,445
-107,437 Reduced 30.12%
249,225 $1.99 Million
Q1 2023

May 12, 2023

SELL
$6.28 - $9.85 $168,969 - $265,024
-26,906 Reduced 7.01%
356,662 $2.89 Million
Q4 2022

Feb 13, 2023

SELL
$6.09 - $7.93 $201,798 - $262,768
-33,136 Reduced 7.95%
383,568 $2.41 Million
Q3 2022

Nov 14, 2022

BUY
$4.58 - $9.21 $822,297 - $1.65 Million
179,541 Added 75.7%
416,704 $2.87 Million
Q2 2022

Aug 12, 2022

BUY
$7.06 - $23.63 $382,115 - $1.28 Million
54,124 Added 29.57%
237,163 $1.98 Million
Q1 2022

May 12, 2022

BUY
$21.6 - $27.79 $322,012 - $414,293
14,908 Added 8.87%
183,039 $4.18 Million
Q4 2021

Feb 10, 2022

BUY
$23.0 - $29.01 $165,439 - $208,668
7,193 Added 4.47%
168,131 $4.64 Million
Q3 2021

Nov 09, 2021

BUY
$25.04 - $30.06 $20,733 - $24,889
828 Added 0.52%
160,938 $4.48 Million
Q2 2021

Aug 11, 2021

BUY
$27.43 - $32.7 $4.39 Million - $5.24 Million
160,110 New
160,110 $4.7 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $3.3B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.